The next 60 Days: a Preview 1. Once everyone gets clear this PR does NOTHING to improve RLV, stock trails back to 2.5-3 cent range.
2. Pumpers get out there to tout the AMAZING potential for selling gloves in North America!!
(They won't mention that AMD Medicom has locked up the Canadian market with a $300+ million, multiyear deal, and that RLV has no chance in hell of competing with established players with established customer relationships.)
Ask yourself: You're a large hospital system that has worked with (McKesson, Cardinal, Medicom....) for decades.. They have a relationship with their team, have trusted their deliveries, have visited their impressive facilities....why would they leave for an unknown player with ZERO distribution facilities, ZERO account managers, ZERO track record and ZERO credibility?
The answer: there is ZERO chance.
Ergo, this North American deal isn't worth the paper it's printed on.
3. In May, Financials for Jan-March 2021 come out: Revenues way down, more net losses...and of course, continued consulting fees paid.
What won't be in those financials: hand sanitizer sales, air purifier sales, COVID-killing neutraceutical sales. In other words, they flopped on 100% of the items they touted as HUGE POTENTIAL via PRs in 2020.
Oh, but forget their 0% success rate in the past five years: they'll crush the glove market.
4. Delays in deliveries caused the proposed launch to slide, due to "items out of RLV's control."
5. The total shares outstanding now exceed 300 million, with over 100 million warrants set to execute at <5 cents. Bye bye upside opportunity.